ASCO 2021 Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in R/R MM
By
City of Hope
FEATURING
Amrita Krishnan
By
City of Hope
FEATURING
Amrita Krishnan
Comments 0
Login to view comments.
Click here to Login